Berthe Hayar
Beirut, BA, Lebanon
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Preclinical models of breast cancer metastasis: strengths, limitations, and clinical relevance.
Journal: NPJ breast cancer
Published: November 01, 2025
Development of Chitosan-Coated Atorvastatin-Loaded Liquid Crystalline Nanoparticles: Intersection of Drug Repurposing and Nanotechnology in Colorectal Cancer Management.
Journal: Pharmaceutics
Published: April 02, 2025
Therapeutic Targeting of the Pentose Phosphate Pathway in Colorectal Cancer Using 6-Aminonicotinamide and 5-Fluorouracil.
Journal: Molecular carcinogenesis
Published: March 06, 2025
Primary effusion lymphoma: therapeutic strategies targeting viral and cellular mechanisms.
Journal: Expert review of anticancer therapy
Published: March 04, 2025
Application of Box-Behnken design in the optimization and development of albendazole-loaded zein nanoparticles as a drug repurposing approach for colorectal cancer management.
Journal: International journal of biological macromolecules
Published: August 08, 2024
Novel ST1926 Nanoparticle Drug Formulation Enhances Drug Therapeutic Efficiency in Colorectal Cancer Xenografted Mice.
Journal: Nanomaterials (Basel, Switzerland)
Published: June 05, 2024
The Antitumor Effect of the DNA Polymerase Alpha Inhibitor ST1926 in Glioblastoma: A Proteomics Approach.
Journal: International journal of molecular sciences
Published: July 31, 2023
Development and Challenges of Synthetic Retinoid Formulations in Cancer.
Journal: Current drug delivery
Published: February 28, 2022
The Effect of Different Ester Chain Modifications of Two Guaianolides for Inhibition of Colorectal Cancer Cell Growth.
Journal: Molecules (Basel, Switzerland)
Published: July 24, 2021
Anticancer activities of parthenolide in primary effusion lymphoma preclinical models.
Journal: Molecular carcinogenesis
Published: January 02, 2020
The synthetic retinoid ST1926 attenuates prostate cancer growth and potentially targets prostate cancer stem-like cells.
Journal: Molecular carcinogenesis
Published: October 25, 2018
Last Updated: 09/26/2026